EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

3-Amidinophenylalanine-Derived Inhibitors’ Antiviral Effect Against H1N1 Influenza A Virus

Lilla Tóth, András Marosi iD, Luna C Schmacke iD, Torsten Steinmetzer iD, Anita Rácz, Dávid Bajusz iD, Ákos Jerzsele iD, Sándor Kunsági-Máté iD, Miklós Poór iD, Erzsébet Pászti-Gere

Antibiotics · 02.04.2026 · 15 (4) · 366

DOI: 10.3390/antibiotics15040366 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antibiotics, online erschienen am 02.04.2026. Verfasst von Lilla Tóth und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, University of Veterinary Medicine, István utca 2, H-1078 Budapest, Hungary. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Veterinary Medicine, Hungarian Ministry for Innovation and Technology, National Research Development and 479 Innovation Office of Hungary.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Transmembrane serine proteases such as TMPRSS2 and matriptase have been identified as pivotal host factors in the influenza A infection due to their capacity to cleave the hemagglutinin and thereby facilitate viral activation. The inhibition of these enzymes has the potential to serve as an effective therapeutic strategy against numerous seasonal influenza strains. In our study, four 3-amidinophenylalanine-derived inhibitors were used to elucidate their antiviral efficacy, pharmacokinetic properties and affinities toward certain related trypsin-like serine proteases.

Methods

Ki values for TMPRSS2, matriptase, thrombin and factor Xa were determined using enzyme kinetic measurements. Cytochrome P450 3A (CYP3A) inhibitory activity was investigated using human liver microsomes, and protein binding was evaluated with human serum albumin and α1-acid glycoprotein. In vitro antiviral efficacy and cytotoxicity were determined in MDCK-II cells.

Results

All compounds were non-cytotoxic and exhibited a relatively high affinity toward matriptase and bovine thrombin in the 10–30 nM concentration range. Among the inhibitors, MI-441 displayed the lowest Ki value for TMPRSS2 (~60 nM). The weakest CYP3A inhibitory activity was observed for compounds MI-447 and MI-448. In addition, three of the four compounds (MI-441, MI-443 and MI-447) demonstrated significant antiviral activity.

Conclusions

This study demonstrates that the investigated inhibitors exhibit a favorable safety profile, low binding to human serum albumin and pronounced antiviral activity against H1N1.

Schlagwörter

Stichwörter der Autor:innen

3-amidinophenylalanineCYP3AH1N1TMPRSS2inhibitorsmatriptaseplasma protein bindingproteolytic cleavagethrombin

Autor:innen und Institutionen

  • Department of Pharmacology and Toxicology, University of Veterinary Medicine, István utca 2, H-1078 Budapest, Hungary.
  • Virology Research Group, Department of Microbiology and Infectious Diseases, University of Veterinary Medicine, Hungária krt 23, H-1143 Budapest, Hungary.
  • Institute of Pharmaceutical Chemistry, Department of Pharmacy, Philipps University Marburg, Marbacher Weg 6-10, 35037 Marburg, Germany.
  • Plasma Chemistry Research Group, HUN-REN Research Centre for Natural Sciences, Magyar tudósok krt. 2, H-1117 Budapest, Hungary.
  • Medicinal Chemistry Research Group and Drug Innovation Centre, HUN-REN Research Centre for Natural Sciences, Magyar tudósok krt. 2, H-1117 Budapest, Hungary.
  • National Laboratory of Infectious Animal Diseases, Antimicrobial Resistance, Veterinary Public Health and Food Chain Safety, University of Veterinary Medicine, István utca 2, H-1078 Budapest, Hungary.

ORCID-Profile: András Marosi, Luna C Schmacke, Torsten Steinmetzer, Dávid Bajusz, Ákos Jerzsele, Sándor Kunsági-Máté, Miklós Poór

Förderung

  • University of Veterinary Medicine
  • Hungarian Ministry for Innovation and Technology
  • National Research Development and 479 Innovation Office of Hungary
  • National Research, Development, and Innovation Office of Hungary
  • Hungarian Academy of Sciences

Zitieren

APA

Tóth, L., Marosi, A., Schmacke, L. C., Steinmetzer, T., Rácz, A., Bajusz, D., Jerzsele, Á., Kunsági-Máté, S., Poór, M., & Pászti-Gere, E. (2026). 3-Amidinophenylalanine-Derived Inhibitors’ Antiviral Effect Against H1N1 Influenza A Virus. Antibiotics, 15(4), 366. https://doi.org/10.3390/antibiotics15040366

Vancouver

Tóth L, Marosi A, Schmacke LC, Steinmetzer T, Rácz A, Bajusz D, et al. 3-Amidinophenylalanine-Derived Inhibitors’ Antiviral Effect Against H1N1 Influenza A Virus. Antibiotics. 2026;15(4):366. doi:10.3390/antibiotics15040366

BibTeX
@article{Tth2026,
  author = {Tóth, Lilla and Marosi, András and Schmacke, Luna C and Steinmetzer, Torsten and Rácz, Anita and Bajusz, Dávid and Jerzsele, Ákos and Kunsági-Máté, Sándor and Poór, Miklós and Pászti-Gere, Erzsébet},
  title = {3-Amidinophenylalanine-Derived Inhibitors’ Antiviral Effect Against H1N1 Influenza A Virus},
  journal = {Antibiotics},
  year = {2026},
  volume = {15},
  number = {4},
  pages = {366},
  doi = {10.3390/antibiotics15040366}
}
Kostenlos starten →